Replies to post #4891 on AVEO Pharmaceuticals, Inc. (AVEO)

[lightrock]

The latest R/S proposal was denied in the last meeting.

Further dilution was approved, and to be expected at least for "go to market" and obviously "float long enough for NDA issues to go through"